Circulating tumour cells: Telling the truth about metastasis

The Lancet Oncology

Volumn 15, Issue 4, 2014, Pages 365-366

  Cristofanilli, Massimo ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST METASTASIS; CANCER PROGNOSIS; CANCER SURVIVAL; CELL COUNT; CELL DENSITY; CIRCULATING TUMOR CELL; HUMAN; NOTE; OVERALL SURVIVAL; PATIENT IDENTIFICATION; PATIENT SELECTION; PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; RISK ASSESSMENT;

BREAST NEOPLASMS; FEMALE; HUMANS; NEOPLASTIC CELLS, CIRCULATING;

EID: 84897445938     PISSN: 14702045     EISSN: 14745488     Source Type: Journal    
DOI: 10.1016/S1470-2045(14)70091-9     Document Type: Note

References (10)

1. Cardoso F, Harbeck N, Fallowfield L, et al. Locally recurrent or metastatic breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol 2012, 23(suppl 7):vii11-vii19.
2. Yu KD, Zhu R, Zhan M, et al. Identification of prognosis-relevant subgroups in patients with chemoresistant triple-negative breast cancer. Clin Cancer Res 2013, 19:2723-2733.
3. Kim MY, Oskarsson T, Acharyya S, et al. Tumor self-seeding by circulating cancer cells. Cell 2009, 139:1315-1326.
4. Allard WJ, Matera J, Miller MC, et al. Tumor cells circulate in the peripheral blood of all major carcinomas but not in healthy subjects or patients with nonmalignant diseases. Clin Cancer Res 2004, 10:6897-6904.
5. Powell AA, Talasaz AH, Zhang H, et al. Single cell profiling of circulating tumor cells: transcriptional heterogeneity and diversity from breast cancer cell lines. PLoS One 2012, 7:e33788.
6. Singh JK, Farnie G, Bundred NJ, et al. Targeting CXCR1/2 significantly reduces breast cancer stem cell activity and increases the efficiency of inhibiting HER2 via HER2-dependent and -independent mechanisms. Clin Cancer Res 2013, 19:643-656.
7. Cristofanilli M, Budd GT, Ellis MJ, et al. Circulating tumor cells, disease progression, and survival in metastatic breast cancer. N Engl J Med 2004, 351:781-791.
8. Budd GT, Cristofanilli M, Ellis MJ, et al. Circulating tumor cells versus imaging: predicting overall survival in metastatic breast cancer. Clin Cancer Res 2006, 12:6403-6409.
9. Harris L, Fritsche H, Mennel R, et al. American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 2007, 25:5287-5312.
10. Bidard F-C, Peeters DJ, Fehm T, et al. Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data. Lancet Oncol 2014, published online March 11. http://dx.doi.org/10.1016/S1470-2045(14)70069-5.